Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.
Press releases published on August 27, 2025
Raíces Naturals Expands Services with Structured Post-Traumatic Growth Program
EIN Presswire
·
August 27, 2025
Raíces Naturals, a Costa Rica–based provider of trauma-informed care, launches its Post-Traumatic Growth program in Costa Rica and via trainings worldwide. WASHINGTON, DC, UNITED STATES, August 27, 2025 /EINPresswire.com/ -- Raíces Naturals, a Costa …
A Platform Seeks to Connect Transitioning Service Members, Military Spouses, and Veterans with Industry Professionals
EIN Presswire
·
August 27, 2025
Post-Veterati seeks to connect transitioning service members, military spouses, and former military professionals with grateful industry professionals. WASHINGTON, DC, UNITED STATES, August 27, 2025 /EINPresswire.com/ -- A former groundbreaking …
Tilray Brands Successfully Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
GlobeNewswire
·
August 27, 2025
NEW YORK and LEAMINGTON, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, …
Tarsus to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
IRVINE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: Wells Fargo 20th Annual Healthcare Conference on Wednesday, …
Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering
GlobeNewswire
·
August 27, 2025
Jericho, New York, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) ("Curanex" or the "Company"), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, …
Jasper Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT (CD117) to address mast cell …
Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
August 27, 2025
MOUNTAIN VIEW, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the …
Supernus Pharmaceuticals to Participate in September Investor Conferences
GlobeNewswire
·
August 27, 2025
ROCKVILLE, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today …
CooperCompanies Announces Third Quarter 2025 Results
GlobeNewswire
·
August 27, 2025
SAN RAMON, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2025. Revenue increased 6% year-over-year to $1,060.3 …
Anaptys Announces Participation in September Investor Conferences
GlobeNewswire
·
August 27, 2025
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of …
Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering
GlobeNewswire
·
August 27, 2025
WESTBROOK, Maine, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (Nasdaq: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced the closing of an underwritten public offering of 1,750,000 shares of common …
Bespoke Extracts, Inc. Announces Financial Results for the Second Quarter ended June 30, 2025
GlobeNewswire
·
August 27, 2025
AURORA, Colo., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (“Bespoke” or the “Company”) (OTCQB: BSPK), today reported its financial results for the quarter ended June 30, 2025. Financial results are reported in accordance with U.S. generally …
Aardvark Therapeutics to Present at Upcoming Investor Conferences in September
GlobeNewswire
·
August 27, 2025
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the …
Acarpia Farmaceutici and EarlyHealth Group Expand Their Partnership to Improve Access in CARICOM and Mexico
GlobeNewswire
·
August 27, 2025
MILAN, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Acarpia Farmaceutici S.r.l., an Italian pharmaceutical manufacturer, and EarlyHealth Group, a global pharmaceutical service provider, have announced the expansion of their strategic partnership to improve access to …
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
August 27, 2025
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …
MannKind to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with …
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
GlobeNewswire
·
August 27, 2025
SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences. The Wells …
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
GlobeNewswire
·
August 27, 2025
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical …
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
GlobeNewswire
·
August 27, 2025
CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …